Literature DB >> 18224273

Dense deposit disease and the factor H H402 allele.

Keith K Lau1, Richard J Smith, Peter C Kolbeck, Lavjay Butani.   

Abstract

Herein, we describe the case of an 8-year-old boy who presented with a nephritic nephrotic syndrome. His laboratory investigation was significant for a persistently low serum complement 3 level. A renal biopsy was performed, based on which, he was diagnosed with dense deposit disease/membranoproliferative glomerulonephritis type II (DDD/MPGN II). He was treated with alternate-day oral corticosteroids, angiotensin-converting enzyme (ACE) inhibitors and tacrolimus. Factor H mutational analysis showed the Y402H and I62V allele polymorphisms. The purpose of our report is to discuss the association of the H402 allele variant of factor H with the DDD/MPGN II phenotype and its possible therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18224273     DOI: 10.1007/s10157-008-0031-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  30 in total

1.  Dense deposit disease: a variant of membranoproliferative glomerulonephritis.

Authors:  R Habib; M C Gubler; C Loirat; H B Mäiz; M Levy
Journal:  Kidney Int       Date:  1975-04       Impact factor: 10.612

2.  Another example of spontaneous improvement in a case of dense deposit disease.

Authors:  M Ikeda; M Honda; O Hasegawa
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

3.  Early recurrence of dense deposit disease with marked endocapillary proliferation after renal transplantation.

Authors:  Kumi Aita; Shinichi Ito; Kazunari Tanabe; Hiroshi Toma; Yutaka Yamaguchi; Michio Nagata
Journal:  Pathol Int       Date:  2006-02       Impact factor: 2.534

4.  Childhood membranoproliferative glomerulonephritis: an approach to management.

Authors:  C D West
Journal:  Kidney Int       Date:  1986-05       Impact factor: 10.612

5.  Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

Authors:  Kevin A Kurtz; Annette J Schlueter
Journal:  J Clin Apher       Date:  2002       Impact factor: 2.821

6.  Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).

Authors:  C Licht; S Heinen; M Józsi; I Löschmann; R E Saunders; S J Perkins; R Waldherr; C Skerka; M Kirschfink; B Hoppe; P F Zipfel
Journal:  Kidney Int       Date:  2006-04-12       Impact factor: 10.612

7.  Further evidence for the antibody nature of C3 nephritic factor (C3NeF).

Authors:  M R Daha; L A van Es
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children.

Authors:  P T McEnery; A J McAdams
Journal:  Am J Kidney Dis       Date:  1988-08       Impact factor: 8.860

9.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Structural basis for complement factor H linked age-related macular degeneration.

Authors:  Beverly E Prosser; Steven Johnson; Pietro Roversi; Andrew P Herbert; Bärbel S Blaum; Jess Tyrrell; Thomas A Jowitt; Simon J Clark; Edward Tarelli; Dusan Uhrín; Paul N Barlow; Robert B Sim; Anthony J Day; Susan M Lea
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  6 in total

1.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

2.  Circulating complement levels and C3 glomerulopathy.

Authors:  Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

3.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

4.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

5.  Kidney function, albuminuria and age-related macular degeneration in NHANES III.

Authors:  Daniel E Weiner; Hocine Tighiouart; Robyn Reynolds; Johanna M Seddon
Journal:  Nephrol Dial Transplant       Date:  2011-02-21       Impact factor: 5.992

Review 6.  C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders.

Authors:  Kultigin Turkmen; Ismail Baloglu; Hakan Ozer
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.